QIAN TANG: Open Payments
NPI 1033657333 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 36 payments from 15 companies in 2025. Trend: 2023 $936 · 2024 $771 · 2025 $870
Food & beverage: $825Education: $45
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $201 |
| Novo Nordisk Inc | 5 | $168 |
| Lilly USA, LLC | 4 | $107 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Exact Sciences Corporation | 2 | $36 |
| HARMONY BIOSCIENCES LLC | 2 | $35 |
| Abbott Laboratories | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $22 |
Products named: KRYSTEXXA, Ozempic, REXULTI, FARXIGA, Kerendia, MOUNJARO, OTEZLA, WAKIX.
Industry payments across GA — which companies pay providers there.
